PolyTherics
London
About PolyTherics
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.1M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2013)
- Website: polytherics.com
- Phone: +44 02076914928
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/polytherics-909266 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.